Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
1.160
-0.010 (-0.85%)
At close: Sep 3, 2026, 4:00 PM EDT
1.160
0.00 (0.00%)
After-hours: Sep 3, 2026, 4:00 PM EDT
Indaptus Therapeutics Employees
Indaptus Therapeutics had 5 employees as of December 31, 2025. The number of employees decreased by 2 or -28.57% compared to the previous year.
Employees
5
Change (1Y)
-2
Growth (1Y)
-28.57%
Revenue / Employee
n/a
Profits / Employee
-$3,084,700
Market Cap
153.20M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 5 | -2 | -28.57% | 5 | 0 |
| Dec 31, 2024 | 7 | 0 | - | 7 | 0 |
| Dec 31, 2023 | 7 | 1 | 16.67% | 7 | 0 |
| Dec 31, 2022 | 6 | 1 | 20.00% | 6 | 0 |
| Dec 31, 2021 | 5 | 3 | 150.00% | 5 | 0 |
| Jun 30, 2021 | 5 | - | - | 5 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Humacyte | 184 |
| Codexis | 146 |
| Molecular Partners AG | 134 |
| Caribou Biosciences | 97 |
| Tenaya Therapeutics | 70 |
| Connect Biopharma Holdings | 64 |
| OnKure Therapeutics | 45 |
| Unicycive Therapeutics | 22 |
INDP News
- 16 days ago - Indaptus Therapeutics files to sell 59M shares of common stock for holders - TheFly
- 17 days ago - Indaptus Therapeutics Registration statement: Registration filing - Filings
- 21 days ago - Indaptus Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 21 days ago - Indaptus Therapeutics Quarterly report: Q2 2026 - Filings
- 21 days ago - Indaptus Therapeutics Earnings release: Q2 2026 - Filings
- 7 weeks ago - Indaptus Therapeutics Proxy statement: Proxy filing - Filings
- 2 months ago - Indaptus Therapeutics files to sell 18.86M shares of common stock for holders - TheFly
- 2 months ago - Indaptus Therapeutics Registration statement: Registration filing - Filings